Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
SLQT vs GOCO vs EHC vs MNSB vs EG
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Medical - Care Facilities
Banks - Regional
Insurance - Reinsurance
SLQT vs GOCO vs EHC vs MNSB vs EG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Insurance - Brokers | Medical - Care Facilities | Banks - Regional | Insurance - Reinsurance |
| Market Cap | $201M | $13M | $10.66B | $176M | $14.17B |
| Revenue (TTM) | $1.64B | $738M | $6.07B | $136M | $17.15B |
| Net Income (TTM) | $73M | $-199M | $609M | $16M | $2.03B |
| Gross Margin | 69.8% | 82.6% | 58.8% | 54.4% | 28.5% |
| Operating Margin | 3.5% | -40.7% | 16.8% | 14.0% | 14.2% |
| Forward P/E | 85.7x | — | 18.1x | 10.4x | 6.7x |
| Total Debt | $416M | $528M | $2.71B | $70M | $3.59B |
| Cash & Equiv. | $32M | $41M | $103M | $25M | $1.32B |
SLQT vs GOCO vs EHC vs MNSB vs EG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | May 26 | Return |
|---|---|---|---|
| SelectQuote, Inc. (SLQT) | 100 | 6.4 | -93.6% |
| GoHealth, Inc. (GOCO) | 100 | 0.4 | -99.6% |
| Encompass Health Co… (EHC) | 100 | 198.0 | +98.0% |
| MainStreet Bancshar… (MNSB) | 100 | 181.8 | +81.8% |
| Everest Re Group, L… (EG) | 100 | 160.7 | +60.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SLQT vs GOCO vs EHC vs MNSB vs EG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SLQT is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 15.5%, EPS growth 106.7%, 3Y rev CAGR 26.0%
- 15.5% revenue growth vs MNSB's -1.4%
Among these 5 stocks, GOCO doesn't own a clear edge in any measured category.
EHC ranks third and is worth considering specifically for long-term compounding.
- 252.2% 10Y total return vs EG's 129.5%
- 8.7% ROA vs GOCO's -15.3%, ROIC 13.9% vs -0.6%
MNSB is the clearest fit if your priority is momentum.
- +26.4% vs GOCO's -88.3%
EG carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 13 yrs, beta 0.36, yield 2.3%
- Lower volatility, beta 0.36, Low D/E 23.2%, current ratio 0.76x
- PEG 0.28 vs EHC's 1.27
- Beta 0.36, yield 2.3%, current ratio 0.76x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.5% revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (6.7x vs 10.4x) | |
| Quality / Margins | 11.9% margin vs GOCO's -27.0% | |
| Stability / Safety | Beta 0.36 vs GOCO's 2.23, lower leverage | |
| Dividends | 2.3% yield, 13-year raise streak, vs EHC's 0.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +26.4% vs GOCO's -88.3% | |
| Efficiency (ROA) | 8.7% ROA vs GOCO's -15.3%, ROIC 13.9% vs -0.6% |
SLQT vs GOCO vs EHC vs MNSB vs EG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SLQT vs GOCO vs EHC vs MNSB vs EG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EG leads in 3 of 6 categories
EHC leads 2 • GOCO leads 1 • SLQT leads 0 • MNSB leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
EG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EG is the larger business by revenue, generating $17.1B annually — 126.2x MNSB's $136M. EG is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to GOCO's -27.0%. On growth, EHC holds the edge at +9.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.6B | $738M | $6.1B | $136M | $17.1B |
| EBITDAEarnings before interest/tax | $63M | -$194M | $1.4B | $23M | $2.5B |
| Net IncomeAfter-tax profit | $73M | -$199M | $609M | $16M | $2.0B |
| Free Cash FlowCash after capex | -$62M | -$78M | $172M | $13M | $2.9B |
| Gross MarginGross profit ÷ Revenue | +69.8% | +82.6% | +58.8% | +54.4% | +28.5% |
| Operating MarginEBIT ÷ Revenue | +3.5% | -40.7% | +16.8% | +14.0% | +14.2% |
| Net MarginNet income ÷ Revenue | +4.5% | -27.0% | +10.0% | +11.5% | +11.9% |
| FCF MarginFCF ÷ Revenue | -3.8% | -10.6% | +2.8% | +7.8% | +16.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.6% | -71.1% | +9.0% | — | -4.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -114.5% | -30.4% | +19.6% | +120.9% | +2.3% |
Valuation Metrics
GOCO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, EG trades at a 89% valuation discount to SLQT's 85.7x P/E. Adjusting for growth (PEG ratio), EG offers better value at 0.38x vs EHC's 1.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $201M | $13M | $10.7B | $176M | $14.2B |
| Enterprise ValueMkt cap + debt − cash | $584M | $500M | $13.3B | $221M | $16.4B |
| Trailing P/EPrice ÷ TTM EPS | 85.71x | -1.50x | 19.35x | 13.36x | 9.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 18.10x | 10.45x | 6.70x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.36x | — | 0.38x |
| EV / EBITDAEnterprise value multiple | 6.57x | 5.05x | 9.61x | 11.58x | 7.95x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 0.02x | 1.80x | 1.30x | 0.82x |
| Price / BookPrice ÷ Book value/share | 0.36x | 0.02x | 3.34x | 0.82x | 0.94x |
| Price / FCFMarket cap ÷ FCF | — | — | 24.26x | 16.57x | 4.16x |
Profitability & Efficiency
EHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
EHC delivers a 18.9% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-64 for GOCO. EG carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to GOCO's 1.15x. On the Piotroski fundamental quality scale (0–9), EHC scores 9/9 vs GOCO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.2% | -64.4% | +18.9% | +7.3% | +13.3% |
| ROA (TTM)Return on assets | +5.7% | -15.3% | +8.7% | +0.7% | +3.3% |
| ROICReturn on invested capital | +5.3% | -0.6% | +13.9% | +5.0% | +8.1% |
| ROCEReturn on capital employed | +6.7% | -0.6% | +17.6% | +0.9% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.72x | 1.15x | 0.83x | 0.32x | 0.23x |
| Net DebtTotal debt minus cash | $384M | $487M | $2.6B | $45M | $2.3B |
| Cash & Equiv.Liquid assets | $32M | $41M | $103M | $25M | $1.3B |
| Total DebtShort + long-term debt | $416M | $528M | $2.7B | $70M | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 4.11x | -4.03x | 6.54x | 0.31x | 18.38x |
Total Returns (Dividends Reinvested)
EHC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EHC five years ago would be worth $16,326 today (with dividends reinvested), compared to $55 for GOCO. Over the past 12 months, MNSB leads with a +26.4% total return vs GOCO's -88.3%. The 3-year compound annual growth rate (CAGR) favors EHC at 20.6% vs GOCO's -57.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.8% | -58.7% | +1.1% | +19.4% | +5.7% |
| 1-Year ReturnPast 12 months | -57.6% | -88.3% | -8.1% | +26.4% | +5.1% |
| 3-Year ReturnCumulative with dividends | -19.7% | -92.3% | +75.4% | +21.5% | -2.3% |
| 5-Year ReturnCumulative with dividends | -96.1% | -99.4% | +63.3% | +20.6% | +41.8% |
| 10-Year ReturnCumulative with dividends | -95.8% | -99.7% | +252.2% | +126.9% | +129.5% |
| CAGR (3Y)Annualised 3-year return | -7.1% | -57.5% | +20.6% | +6.7% | -0.8% |
Risk & Volatility
EG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EG is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than GOCO's 2.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EG currently trades 95.5% from its 52-week high vs GOCO's 11.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.96x | 2.23x | 0.40x | 0.66x | 0.36x |
| 52-Week HighHighest price in past year | $2.80 | $8.75 | $127.99 | $25.17 | $368.29 |
| 52-Week LowLowest price in past year | $0.56 | $0.99 | $92.77 | $17.86 | $302.44 |
| % of 52W HighCurrent price vs 52-week peak | +40.7% | +11.3% | +83.7% | +93.4% | +95.5% |
| RSI (14)Momentum oscillator 0–100 | 71.7 | 35.0 | 53.6 | 50.4 | 58.9 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 78K | 921K | 58K | 310K |
Analyst Outlook
EG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SLQT as "Hold", EHC as "Buy", MNSB as "Hold", EG as "Hold". Consensus price targets imply 250.9% upside for SLQT (target: $4) vs 0.7% for EG (target: $354). For income investors, EG offers the higher dividend yield at 2.30% vs EHC's 0.65%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $4.00 | — | $153.00 | — | $354.00 |
| # AnalystsCovering analysts | 11 | — | 26 | 1 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.6% | — | +2.3% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 2 | 2 | 13 |
| Dividend / ShareAnnual DPS | — | — | $0.70 | — | $8.09 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +12.1% | +1.5% | 0.0% | +5.8% |
EG leads in 3 of 6 categories (Income & Cash Flow, Risk & Volatility). EHC leads in 2 (Profitability & Efficiency, Total Returns).
SLQT vs GOCO vs EHC vs MNSB vs EG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SLQT or GOCO or EHC or MNSB or EG a better buy right now?
For growth investors, SelectQuote, Inc.
(SLQT) is the stronger pick with 15. 5% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Everest Re Group, Ltd. (EG) offers the better valuation at 9. 3x trailing P/E (6. 7x forward), making it the more compelling value choice. Analysts rate Encompass Health Corporation (EHC) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SLQT or GOCO or EHC or MNSB or EG?
On trailing P/E, Everest Re Group, Ltd.
(EG) is the cheapest at 9. 3x versus SelectQuote, Inc. at 85. 7x. On forward P/E, Everest Re Group, Ltd. is actually cheaper at 6. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Everest Re Group, Ltd. wins at 0. 28x versus Encompass Health Corporation's 1. 27x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SLQT or GOCO or EHC or MNSB or EG?
Over the past 5 years, Encompass Health Corporation (EHC) delivered a total return of +63.
3%, compared to -99. 4% for GoHealth, Inc. (GOCO). Over 10 years, the gap is even starker: EHC returned +252. 2% versus GOCO's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SLQT or GOCO or EHC or MNSB or EG?
By beta (market sensitivity over 5 years), Everest Re Group, Ltd.
(EG) is the lower-risk stock at 0. 36β versus GoHealth, Inc. 's 2. 23β — meaning GOCO is approximately 513% more volatile than EG relative to the S&P 500. On balance sheet safety, Everest Re Group, Ltd. (EG) carries a lower debt/equity ratio of 23% versus 115% for GoHealth, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SLQT or GOCO or EHC or MNSB or EG?
By revenue growth (latest reported year), SelectQuote, Inc.
(SLQT) is pulling ahead at 15. 5% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 19. 1% for Everest Re Group, Ltd.. Over a 3-year CAGR, SLQT leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SLQT or GOCO or EHC or MNSB or EG?
MainStreet Bancshares, Inc.
(MNSB) is the more profitable company, earning 11. 5% net margin versus -0. 4% for GoHealth, Inc. — meaning it keeps 11. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHC leads at 17. 7% versus -0. 9% for GOCO. At the gross margin level — before operating expenses — EHC leads at 95. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SLQT or GOCO or EHC or MNSB or EG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Everest Re Group, Ltd. (EG) is the more undervalued stock at a PEG of 0. 28x versus Encompass Health Corporation's 1. 27x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Everest Re Group, Ltd. (EG) trades at 6. 7x forward P/E versus 18. 1x for Encompass Health Corporation — 11. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SLQT: 250. 9% to $4. 00.
08Which pays a better dividend — SLQT or GOCO or EHC or MNSB or EG?
In this comparison, EG (2.
3% yield), EHC (0. 6% yield) pay a dividend. SLQT, GOCO, MNSB do not pay a meaningful dividend and should not be held primarily for income.
09Is SLQT or GOCO or EHC or MNSB or EG better for a retirement portfolio?
For long-horizon retirement investors, Encompass Health Corporation (EHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
40), 0. 6% yield, +252. 2% 10Y return). GoHealth, Inc. (GOCO) carries a higher beta of 2. 23 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EHC: +252. 2%, GOCO: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SLQT and GOCO and EHC and MNSB and EG?
These companies operate in different sectors (SLQT (Financial Services) and GOCO (Financial Services) and EHC (Healthcare) and MNSB (Financial Services) and EG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SLQT is a small-cap high-growth stock; GOCO is a small-cap quality compounder stock; EHC is a mid-cap quality compounder stock; MNSB is a small-cap deep-value stock; EG is a mid-cap deep-value stock. EHC, EG pay a dividend while SLQT, GOCO, MNSB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.